Novel ocular antihypertensive compounds in clinical trials.
2011
Introduction:
Glaucoma is a multifactorial disease characterized by progressive optic nerve injury and visual field defects. Elevated intraocular pressure (IOP) is the most widely recognized risk factor for the onset and progression of open-angle glaucoma, and IOP-lowering medications comprise the primary treatment strategy. IOP elevation in glaucoma is associated with diminished or obstructed aqueous humor outflow. Pharmacotherapy reduces IOP by suppressing aqueous inflow and/or increasing aqueous outflow.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
94
References
84
Citations
NaN
KQI